RecruitingPhase 4NCT06717919
HOPE Against Cancer Recurrence in HCC
Studying Pediatric hepatocellular carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Philipp Dutkowski
- Intervention
- Hypothermic oxygenated perfusion(procedure)
- Enrollment
- 220 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2028
Study locations (30)
- Rutgers New Jersey Medical School (New York), New York, New York, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- Medical University of Innsbruck, Innsbruck, Austria
- Medical University of Vienna, Vienna, Austria
- University Hospitals Leuven, Leuven, Belgium
- Institut de Recherche Expérimentale et Clinique (IREC) UCLouvain (Brussels), Woluwe-Saint-Lambert, Belgium
- Institute for Clinical and Experimental Medicine (IKEM) (Prague), Prague, Czechia
- Copenhagen University Hospital, Copenhagen, Denmark
- Hôpital de la Croix-Rousse (Lyon), Lyon, France
- Universitätsklinikum Essen, Essen, Germany
- University Medical Centre Hamburg-Eppendorf, Hamburg-Eppendorf, Germany
- Hannover Medical School, Hanover, Germany
- University of Heidelberg, Heidelberg, Germany
- University of Mainz, Mainz, Germany
- University of Munich Grosshadern, München, Germany
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06717919 on ClinicalTrials.govOther trials for Pediatric hepatocellular carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07328009A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular CarcinomaFudan University
- RECRUITINGNCT07295340Diagnostic Accuracy of Folate-Targeted NIR-II Carbon Dots for Ex Vivo HCC DetectionWest China Hospital
- RECRUITINGPHASE1NCT07364357A Phase I Study of CREPT-618 in Locally Advanced HCCCancer Institute and Hospital, Chinese Academy of Medical Sciences
- RECRUITINGNCT07173868FDG PET-CT in Advanced Breast CancerSamsung Medical Center
- RECRUITINGNANCT06899152HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver CancerMontefiore Medical Center
- RECRUITINGPHASE1, PHASE2NCT07053488CRISPR-Edited HLA Donor Liver Transplant to Reduce RejectionAMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
- RECRUITINGNANCT06934018Effect of Surgical Margin Width on Recurrence and Survival in Patients With Hepatic Oligometastasis of Colorectal CancerFudan University
- RECRUITINGPHASE3NCT06900543Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphereChengdu New Radiomedicine Technology Co. LTD.